Company Overview and News

0
5 Safe and Sound ETF Strategies for 2H

2018-07-12 investorplace
After a bumpy ride in the first half of the year, global stocks are bouncing back, with iShares MSCI ACWI Index Fund (NASDAQ:ACWI), which targets the global stock market, up 1% last week. The U.S. stocks, as indicated by SPDR S&P 500 ETF (NYSEARCA:SPY), which tracks the S&P 500 index, is up 1.5% to start the second half versus 0.6% gain for Vanguard FTSE All-World ex-US ETF (NYSEARCA:VEU), which targets the international equity market excluding the United States.
ACWI ALFA FBT VTV PSCT AIRR IJT VBK FV FTLB

44
7 Best Vanguard Funds for the Second Half of 2018 | InvestorPlace

2018-07-11 investorplace
The S&P 500 gained 2.5% in the first half of the year, delivering a decent though not jaw-dropping performance. With the second half of the year, now could be an ideal time for some investors to consider reconfiguring their portfolios or buy some of the first half’s outperforming (or laggard) funds.
FB AMZN T GOOGL VIGI AAPL VZ NFLX NYTAB GOOG VBK VWO

0
5 Safe and Sound ETF Strategies for 2H

2018-07-09 zacks
After a bumpy ride in the first half of the year, global stocks are bouncing back, with iShares MSCI ACWI ETF (ACWI - Free Report) , which targets the global stock market, up 1% last week. The U.S. stocks, as indicated by SPDR S&P 500 ETF (SPY - Free Report) , which tracks the S&P 500 index, is up 1.5% to start the second half versus 0.6% gain for Vanguard FTSE All-World ex-US ETF VEU, which targets the international equity market excluding the United States.
ACWI IWO ALFA FBT VTV IVE VEU XSW IBLN VBK FV

0
6 Small-Cap ETFs That Have Surged to #1 This Summer

2018-06-25 investorplace
The U.S. stock market has started to feel the heat of summer in some corners. While the S&P 500 and the Dow Jones Industrial Average have seen a summer lull so far, the Russell 2000 index and Nasdaq Composite index have been burning with impressive gains of 3.6% and 3.5%, respectively, over the past one month.
IJT VBK

4
6 Small-Cap ETFs That Have Surged to #1 Rank in Summer

2018-06-25 zacks
The U.S. stock market has started to feel the heat of summer in some corners. While the S&P 500 and the Dow Jones Industrial Average have seen a summer lull so far, the Russell 2000 index and Nasdaq Composite index have been burning with impressive gains of 3.6% and 3.5%, respectively, over the past one month. Small-cap stocks seem to be the hottest investment cluster for this summer. This is especially true in the wake of escalating trade tensions between the United States and some of its key partners, and bouts of upbeat data showing encouraging domestic economic fundamentals.
IWO KHC VIOG SLYG VBK

1
How to Build a Winning ETF Portfolio Amid Trade War Fears

2018-06-22 zacks
The global stock market has been on a bumpy ride given fears of a global trade war that has kept investors’ on the edge. This is especially true in the wake of escalating tariff talks between the United States and its major allies, especially China. However, economic fundamentals remained sound given the raft of upbeat data, which shows that the economy is piping hot with unemployment dropping to 3.
FNDX IWO BBH SCHV SLYG IGM VBK SPYV

24
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

2018-06-18 zacks
If you're interested in broad exposure to the Small Cap Growth segment of the US equity market, look no further than the First Trust Small Cap Growth AlphaDEX Fund (FYC - Free Report) , a passively managed exchange traded fund launched on 04/19/2011.
FYC TWLO IWO WWE VBK AAXN

0
5 Small-Cap ETFs With Big-Time Upside Potential

2018-05-27 investorplace
Small-cap stocks and the corresponding exchange traded funds (ETFs) are on a tear. Over the past week, the widely followed Russell 2000 index is up nearly 3%, bringing its year-to-date gain to over 7%. By comparison, the large-cap S&P 500 is up just over 3% this year.
VBK

49
Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?

2018-05-22 zacks
Looking for broad exposure to the Small Cap Growth segment of the US equity market? You should consider the Vanguard S&P Small-Cap 600 Growth ETF (VIOG - Free Report) , a passively managed exchange traded fund launched on 09/09/2010.
IWO ASGN VIOG CHE FIVE VBK AKAM

12
Should Guggenheim S&P SmallCap 600 Pure Growth ETF (RZG) Be on Your Investing Radar?

2018-05-21 zacks
If you're interested in broad exposure to the Small Cap Growth segment of the US equity market, look no further than the Guggenheim S&P SmallCap 600 Pure Growth ETF (RZG - Free Report) , a passively managed exchange traded fund launched on 03/01/2006.
ENTA IWO QLYS RZG VBK CSIQ BEAT

0
5 Market-Beating Small-Cap ETFs Trading at New Highs

2018-05-16 investorplace
Wall Street has been on a roller-coaster ride this year. Yet, the small-cap segment of the broader market has been outperforming, defying extremely volatility. This is especially true as the Russell 2000 is nearing its record levels with just less than 1% away from its peak.
FYC VTWO IJT VBK

20
Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar?

2018-05-16 zacks
If you're interested in broad exposure to the Small Cap Growth segment of the US equity market, look no further than the Vanguard Russell 2000 Growth ETF (VTWG - Free Report) , a passively managed exchange traded fund launched on 09/22/2010.
VTWG SAGE NKTR IWO GRUB VBK

6
5 Market-Beating Small-Cap ETFs Trading at New Highs

2018-05-15 zacks
Wall Street has been on a roller-coaster ride this year. Yet, the small-cap segment of the broader market has been outperforming, defying extremely volatility. This is especially true as the Russell 2000 is nearing its record levels with just less than 1% away from its peak (read: What Makes Small-Cap ETFs Winners This Year). Why Small Caps? Global sentiments have been deteriorating due to lack of progress in U.
FYC GD VTWO CSX IWM VBK

20
Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?

2018-04-24 zacks
Looking for broad exposure to the Small Cap Growth segment of the US equity market? You should consider the Vanguard S&P Small-Cap 600 Growth ETF (VIOG - Free Report) , a passively managed exchange traded fund launched on 09/09/2010.
CMN NKTR IWO VIOG CMD CHE VBK

28
Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar?

2018-04-11 zacks
If you're interested in broad exposure to the Small Cap Growth segment of the US equity market, look no further than the Vanguard Russell 2000 Growth ETF (VTWG - Free Report) , a passively managed exchange traded fund launched on 09/22/2010.
WFC WFCNP WFC.WS WFC.PRL WFC.PRJ VBK EXAS VTWG WFC.PRT WFC.PRR IWO WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 922908595